Barinthus Biotherapeutics plc (BRNS) Tops Q3 EPS by 4c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q3 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Northland Upgrades Evolution Petroleum (EPM) to Outperform 'on Pullback & Attractive Royalty Acquisition'
• Marvell Technology (MRVL) Tops Q2 EPS by 1c, Offers Guidance
• SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance